about
Field cancerisation in colorectal cancer: a new frontier or pastures past?Clinical implications and utility of field cancerizationROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladderA novel homogeneous irradiation fiber probe for whole bladder wall photodynamic therapy.Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterationsA Cancer-Indicative microRNA Pattern in Normal Prostate Tissue.Bladder cancer: clinical and pathological profile.Clinical significance of survivin expression in patients with urothelial carcinoma.DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells.Benzalkonium bromide as a new potential instillation drug for bladder cancer: hypothesis and pilot study.c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine.Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.
P2860
Q26862851-806B5D0E-EBEC-4285-8C3E-DAA3FDBEBC86Q33278836-CAA7D60D-F9D7-4306-B043-E29B925EF273Q34059983-632A5754-19D6-4A01-9196-0DA5EFA83BF3Q34172826-4C83596F-5AC5-4560-9879-DD05E6752AC0Q34734078-B930524B-C74A-4581-9E4E-A23FE9520988Q36790412-C1E1027F-85B4-434A-AB19-AA12834FCB24Q37278983-2FD3F1CE-28FB-4D72-A55E-4FD4C06C1D85Q37600971-44973267-7FC3-45F9-8E7E-6A42EC54D257Q37961740-875181DF-31B8-40E2-A97A-830FC9F5EF88Q38027302-C86316B7-1C51-4603-BE7D-2C951979F57CQ39304455-0A29F492-B5FA-413A-B0AE-682BED56F43BQ39889711-DBE2A8E8-0EEA-4F9E-9EE6-259264420686Q40095771-17209967-C57F-408D-B235-5546DCA29708Q46680025-DE1F2CEA-660B-46E9-904A-0F1E8E7ED428Q47788273-4C1D1BD9-F4A4-4E04-A17D-2C2D540908D8Q50317911-A4CC27D9-1A6F-4737-91A3-E0AA23FD0DC2
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Development and progression of urothelial carcinoma.
@ast
Development and progression of urothelial carcinoma.
@en
type
label
Development and progression of urothelial carcinoma.
@ast
Development and progression of urothelial carcinoma.
@en
prefLabel
Development and progression of urothelial carcinoma.
@ast
Development and progression of urothelial carcinoma.
@en
P2860
P1433
P1476
Development and progression of urothelial carcinoma.
@en
P2093
Tadao Kakizoe
P2860
P304
P356
10.1111/J.1349-7006.2006.00264.X
P577
2006-07-04T00:00:00Z